Inovio shares tumble as RBC downgrades stock, but analysts still believe in its technology
March 13, 2020 at 10:38 AM EDT
Shares of biotech Inovio Pharmaceuticals Inc. fell more than 20% Friday, as analysts weighed in on the company’s latest earnings and RBC downgraded the stock on valuation grounds.